Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy cooperative oncology group

Journal of Clinical Oncology

Volumn 18, Issue 7, 2000, Pages 1451-1457

  Comella, Pasquale ^a   Frasci, Giuseppe ^a   Panza, Nicola ^a   Manzione, Luigi ^a   De Cataldis, Giuseppe ^a   Cioffi, Riccardo ^a   Maiorino, Luigi ^a   Micillo, Enrico ^a   Lorusso, Vito ^a   Di Rienzo, Gaetano ^a   Filippelli, Gianfranco ^a   Lamberti, Alfredo ^a   Natale, Michele ^a   Bilancia, Domenico ^a   Nicolella, Gianpaolo ^a   Di Nota, Angelo ^a   Comella, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; GEMCITABINE; NAVELBINE; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; ITALY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUROPATHY; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; VOMITING;

EID: 0034076846     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.7.1451     Document Type: Article

References (30)

1. Boring CC, Squires TS, Tong TT, et al: Cancer statistics. CA Cancer J Clin 44:7-26, 1994
2. Gralla R: New directions in non-small cell lung cancer. Semin Oncol 17:20-29, 1990 (suppl 7)
3. Non-Small Cell Lung Cancer Cooperative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patient data from 52 randomised clinical trials. BMJ 311:899-909, 1995
4. Lilenbaum RC, Green MR: Novel chemotherapeutic agents in the treatment of non-small cell lung cancer. J Clin Oncol 11:1391-1402, 1993
5. Le Chevalier T, Brisgand D, Douillard JY, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European Multicenter Trial including 612 patients. J Clin Oncol 12:360-366, 1994
6. Wozniak AJ, Crowley JJ, Balcezark SP, et al: Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non - small-cell lung cancer (NSCLC): A Southwest Oncology Group study. J Clin Oncol 16:2459-2465, 1998
7. Klastersky J, Sculier JP: Dose-finding of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer. Lung Cancer 12:S117-S125, 1995 (suppl 2)
8. Langer CJ, Leighton JC, Comis RL, et al: Paclitaxel and carboplatin in combination in the treatment of advanced non - small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995
9. Bonomi P, Kim K, Kluger J, et al: Comparison of survival for stage IIIB versus IV non - small-cell lung cancer patients treated with etoposide-cisplatin versus Taxol-cisplatin: An Eastern Cooperative Group trial. Proc Am Soc Clin Oncol 16:454a, 1997 (abstr 1631)
10. Giaccone G, Splinter TA, Debruyne C, et al: Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non - small-cell lung cancer: The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 16:2133-2141, 1998
11. Crinò L, Scagliotti G, Marangolo M, et al: Cisplatin-gemcitabine combination in advanced non-small cell lung cancer: A phase II study. J Clin Oncol 15:297-303, 1997
12. Abratt RP, Bezwoda WR, Goedhals L, et al: Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non - small-cell lung cancer. J Clin Oncol 15:744-750, 1997
13. Cardenal F, Cabrerizo PL, Anton A, et al: Randomized phase III study of Gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non - small-cell lung cancer. J Clin Oncol 17:12-18, 1999
14. Crinò L, Conte P, De Marinis F, et al: A randomized trial of gemcitabine, cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non - small-cell lung cancer: A multicenter phase III study. Proc Am Soc Clin Oncol 17:455a, 1998 (abstr 1750)
15. Belani CP, Natale RB, Lee JS, et al: Randomized phase III trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non - small-cell lung cancer. Proc Am Soc Clin Oncol 17:455a, 1998 (abstr 1751)
16. Gatzemeier U, von Pawel J, Gottfried M, et al: Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non - small-cell lung cancer. Proc Am Soc Clin Oncol 17:454a, 1998 (abstr 1748)
17. Sandler A, Nemunaitis J, Dehnam C, et al: Phase III study of cisplatin with or without gemcitabine in patients with advanced NSCLC. Proc Am Soc Clin Oncol 17:454, 1998 (abstr 1747)
18. Kelly K, Crowley J, Bunn PA, et al: A randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in untreated advanced non - small-cell lung cancer (NSCLC): A Southwest Oncology Group (SWOG) trial. Proc Am Soc Clin Oncol 18:461a, 1999 (abstr 1777)
19. Frasci G, Panza N, Comella P, et al: Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small cell lung cancer. Ann Oncol 8:1045-1048, 1997
20. Comella P, Frasci G, Panza N, et al: Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non - small-cell lung cancer (NSCLC): A phase II randomized study of the Southern Italy Cooperative Oncology Group phase II randomized study. J Clin Oncol 17:1525-1534, 1999
21. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
22. Hollen PJ, Gralla RJ, Kris MG, et al: Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale. Eur J Cancer 29A:S51-S58, 1993 (suppl 1)
23. Frasci G, Comella P, Panza N, et al: Carboplatin-oral etoposide personalized dosing in elderly NSCLC patients. Eur J Cancer 34:1710-1714, 1998
24. Schaid DJ, Wieand S, Therneau TM: Optimal two-stage screening designs for survival comparisons. Biometrika 77:507-513, 1990
25. Cox DR: Regression models and life tables. J R Stat Assoc 34:187-220, 1972
26. Kaplan ES, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:557-580, 1958
27. Comella P, Frasci G, De Cataldis G, et al: Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small cell lung cancer: A multicenter randomised trial. Br J Cancer 74:1805-1811, 1996
28. Johnson DH, Zhu J, Schiller J, et al: E 1594: A randomized phase III trial in metastatic non - small-cell lung cancer (NSCLC) - Outcome of PS2 patients: An Eastern Cooperative Group trial (ECOG). Proc Am Soc Clin Oncol 18:461a, 1999 (abstr 1779)
29. Frasci G, Lorusso V, Panza N, et al: Gemcitabine + vinorelbine vs. vinorelbine alone in elderly non-small cell lung cancer patients: Interim analysis of a SICOG phase III trial. 10th International Congress on Anti-Cancer Treatment, Paris, France, January 31-February 3, 2000 (abstr S3-07)
30. Smith IE, O'Brien MER, Norton A, et al: Duration of chemotherapy for advanced non - small-cell lung cancer: A phase III randomized trial of 3 versus 6 courses of mitomycin C, vinblastine, cisplatin. Proc Am Soc Clin Oncol 17:457a, 1998 (abstr 1759)